These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30831026)

  • 1. Isotope Corrected Chiral and Achiral Nontargeted Metabolomics: An Approach for High Accuracy and Precision Metabolomics Based on Derivatization and Its Application to Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Takayama T; Mizuno H; Toyo'oka T; Akatsu H; Inoue K; Todoroki K
    Anal Chem; 2019 Apr; 91(7):4396-4404. PubMed ID: 30831026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral Metabolomics Using Triazine-Based Chiral Labeling Reagents by UPLC-ESI-MS/MS.
    Toyo'oka T
    Methods Mol Biol; 2019; 1985():57-79. PubMed ID: 31069729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of chiral and achiral carboxylic acid metabolomics: synthesis and evaluation of triazine-type chiral derivatization reagents for carboxylic acids by LC-ESI-MS/MS and the application to saliva of healthy volunteers and diabetic patients.
    Takayama T; Kuwabara T; Maeda T; Noge I; Kitagawa Y; Inoue K; Todoroki K; Min JZ; Toyo'oka T
    Anal Bioanal Chem; 2015 Jan; 407(3):1003-14. PubMed ID: 25366977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach for LC-MS/MS-based chiral metabolomics fingerprinting and chiral metabolomics extraction using a pair of enantiomers of chiral derivatization reagents.
    Takayama T; Mochizuki T; Todoroki K; Min JZ; Mizuno H; Inoue K; Akatsu H; Noge I; Toyo'oka T
    Anal Chim Acta; 2015 Oct; 898():73-84. PubMed ID: 26526912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel chiral derivatization reagents possessing a pyridylthiourea structure for enantiospecific determination of amines and carboxylic acids in high-throughput liquid chromatography and electrospray-ionization mass spectrometry for chiral metabolomics identification.
    Nagao R; Tsutsui H; Mochizuki T; Takayama T; Kuwabara T; Min JZ; Inoue K; Todoroki K; Toyo'oka T
    J Chromatogr A; 2013 Jun; 1296():111-8. PubMed ID: 23582770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Accuracy Check Using Common Background Peaks for Improving Metabolome Data Quality in Chemical Isotope Labeling LC-MS.
    Li Y; Li L
    J Am Soc Mass Spectrom; 2019 Sep; 30(9):1733-1741. PubMed ID: 31140076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS analysis of the central energy and carbon metabolites in biological samples following derivatization by dimethylaminophenacyl bromide.
    Willacey CCW; Naaktgeboren M; Lucumi Moreno E; Wegrzyn AB; van der Es D; Karu N; Fleming RMT; Harms AC; Hankemeier T
    J Chromatogr A; 2019 Dec; 1608():460413. PubMed ID: 31395359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the chiral metabolomics: Liquid chromatography-mass spectrometry based DL-amino acid analysis after labeling with a new chiral reagent, (S)-2,5-dioxopyrrolidin-1-yl-1-(4,6-dimethoxy-1,3,5-triazin-2-yl)pyrrolidine-2-carboxylate, and the application to saliva of healthy volunteers.
    Mochizuki T; Takayama T; Todoroki K; Inoue K; Min JZ; Toyo'oka T
    Anal Chim Acta; 2015 May; 875():73-82. PubMed ID: 25937108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies.
    Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective Amine-omics Using Heavy Atom Isotope Labeled l- and d-Marfey's Reagents.
    Mishra NR; Gutheil WG
    J Am Soc Mass Spectrom; 2024 Jun; 35(6):1217-1226. PubMed ID: 38683793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a series of prolylamidepyridines as the chiral derivatization reagents for enantioseparation of carboxylic acids by LC-ESI-MS/MS and the application to human saliva.
    Kuwabara T; Takayama T; Todoroki K; Inoue K; Min JZ; Toyo'oka T
    Anal Bioanal Chem; 2014 Apr; 406(11):2641-9. PubMed ID: 24500756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review.
    Higashi T; Ogawa S
    J Pharm Biomed Anal; 2016 Oct; 130():181-193. PubMed ID: 27178301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural isotope correction of MS/MS measurements for metabolomics and (13)C fluxomics.
    Niedenführ S; ten Pierick A; van Dam PT; Suarez-Mendez CA; Nöh K; Wahl SA
    Biotechnol Bioeng; 2016 May; 113(5):1137-47. PubMed ID: 26479486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Approach to Disease Using Non-invasive Samples Based on Derivatization and LC-ESI-MS/MS.
    Toyo'oka T
    Biol Pharm Bull; 2016; 39(9):1397-411. PubMed ID: 27582321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitive liquid chromatography-tandem mass spectrometry-based chiral metabolic profiling focusing on amino acids and related metabolites.
    Nakano Y; Taniguchi M; Fukusaki E
    J Biosci Bioeng; 2019 Apr; 127(4):520-527. PubMed ID: 30563742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry.
    Pandey R; Collins M; Lu X; Sweeney SR; Chiou J; Lodi A; Tiziani S
    Anal Chem; 2021 Apr; 93(14):5805-5814. PubMed ID: 33818082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in isotope-coded derivatization liquid chromatographic-mass spectrometric analyses with special emphasis on their biomedical application.
    El-Maghrabey MH; Kishikawa N; Kuroda N
    Biomed Chromatogr; 2020 Mar; 34(3):e4756. PubMed ID: 31755123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model.
    Wang X; Han W; Yang J; Westaway D; Li L
    Anal Chim Acta; 2019 Mar; 1050():95-104. PubMed ID: 30661596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.